Overview
Today’s session produced 17 continuation breakout signals, a healthy count that signals broad market participation despite the Cautious regime classification. Breadth sits at 55.8% above SMA-40 with Bullish/Neutral sentiment — constructive but not euphoric. The leadership rotation into Health Care (3.4% ATR%) and Communication Services (3.4% ATR%) is clearly visible in today’s top candidates, with Medical/Biotech names (KYMR, NUVB, EDIT) dominating the highest-quality setups. Technology, Industrials, and Utilities show negative ATR% expansion, confirming these sectors are contracting rather than trending — a headwind for tech-heavy names like SNPS and SMCI despite strong headline moves.
Quality Score: 3.5/5. Signal count and institutional participation are strong (SNPS at 3,474 funds, SE at 1,913 funds, SMCI at 1,582 funds), but average RVOL across the group is mixed — several names show sub-1.0 RVOL despite double-digit percentage gains, which tempers conviction in a Cautious regime. Sector diversity is good (Medical, Finance, Retail, Mining, Software all represented), avoiding single-theme concentration risk. Given the regime’s instruction to be selective, only the cleanest volume-confirmed setups in leading sectors earn top-tier scores today.
Top 5 Picks
EDIT ($3.28) — Medical (Development Biotech)
Technical Setup: EDIT is pushing directly into its 4h supply zone (3.28–3.455) with RVOL of 1.9 and a 9.3% daily gain — strong volume confirmation of the breakout attempt. ATR%-M of 1.7 shows expanding volatility, and the Medical sector is today’s top ATR% leader (3.4%), giving this setup regime tailwind. A clean break above 3.455 would confirm continuation toward the monthly demand-to-supply range extension.
| Level | Price |
|---|---|
| Entry | $3.35 (breakout confirmation above supply) |
| Stop | $3.00 (below monthly demand upper bound) |
| Target | $3.90 (+16.4% from entry) |
Institutional Backing: 193 funds holding, classified across Buckets B0/B1/B2 — broad institutional footprint for a small-cap biotech.
KYMR ($126.64) — Medical (Development Biotech)
Technical Setup: KYMR sits right at its 30m supply level (126.64–127.36) with a 4.6% gain on RVOL 1.4 and rising ATR%-M of 3.6. Only 2.6% off its 52-week high, this is a leadership name in the sector currently topping the ATR% rankings. The daily demand zone (106.30–109.62) sits far below, confirming a well-supported uptrend structure.
| Level | Price |
|---|---|
| Entry | $127.50 (break above supply) |
| Stop | $122.00 (-4.3%, near ADR) |
| Target | $135.00 (+5.9% from entry) |
Institutional Backing: 580 funds, Buckets B0/B1 — one of the strongest institutional sponsorship levels among today’s candidates.
SNPS ($408.79) — Software (Design)
Technical Setup: SNPS shows the highest RVOL in today’s list at 2.0, sitting essentially at its weekly demand zone (408.50 lower bound is 0.07% away). Massive institutional footprint offers a strong support base even though sector ATR% is soft. The tight distance to supply (417.08–423.21, only 2.03% away) offers a favorable risk/reward if demand holds.
| Level | Price |
|---|---|
| Entry | $409.50 (hold above weekly demand) |
| Stop | $397.00 (-3.1%, below demand structure) |
| Target | $422.00 (+3.1% into supply zone) |
Institutional Backing: 3,474 funds (INST), Bucket B1 — the largest institutional base in today’s entire signal group.
SE ($123.18) — Retail (Internet)
Technical Setup: SE gained 6.5% with strong ATR%-M expansion of 3.9, currently trading between its daily demand (114.14–116.78) and 30m supply (128.71–129.83) zones. RVOL of 1.0 is average but the structural momentum and institutional depth support continuation toward supply.
| Level | Price |
|---|---|
| Entry | $124.50 (momentum confirmation) |
| Stop | $119.00 (-4.4%) |
| Target | $129.50 (+4.0% into supply) |
Institutional Backing: 1,913 funds (INST), Bucket B1 — solid large-cap sponsorship.
BULL ($8.94) — Finance (Investment Banking)
Technical Setup: BULL rallied 4.8% on RVOL 1.7 with ATR%-M of 3.5, approaching its daily supply zone (9.16–9.985, 2.46% away). The 30m demand zone (8.4554–8.5204) sits just below current price, providing a defined risk boundary for a breakout attempt.
| Level | Price |
|---|---|
| Entry | $9.20 (break of near-term resistance) |
| Stop | $8.45 (-8.2%, below demand zone) |
| Target | $9.95 (+8.2% into supply) |
Institutional Backing: 153 funds, Buckets B0/B1/B2 — moderate but diversified sponsorship.
Honorable Mentions
- SMCI ($38.46): Big 9.3% move and 1,582 funds backing, but RVOL of only 0.9 keeps this a watch-and-confirm name.
- NUVB ($7.10): Sitting right at daily demand with 5.0% gain, but weak RVOL of 0.7 limits conviction.
- TIC ($9.75): Between zones with decent ATR%-M of 3.6, though sub-1.0 RVOL tempers the breakout signal.
- UUUU ($15.97): Strong 7.3% move approaching 30m supply, RVOL of 1.1 is acceptable but not standout.
- EVH ($4.89): Modest 3.6% gain but very low ATR%-M of 0.4 suggests limited volatility expansion.
Strategy Summary
Today’s continuation setups skew toward Medical/Biotech leadership, aligning directly with the top-performing sector by ATR%. The Cautious regime warrants selectivity, and the five picks above stand out for combining volume confirmation, favorable zone positioning, and institutional depth. Risk/reward across the group ranges from roughly 4% to 8% stop distances against 4–16% upside targets, offering asymmetric setups when entries are confirmed on breakout follow-through rather than chased at current levels. Avoid tech-sector names with weak RVOL confirmation given the sector’s negative ATR% backdrop today.